Literature DB >> 11744315

Neurophysiologic studies in congenital insensitivity to pain with anhidrosis.

Z Shorer1, S W Moses, E Hershkovitz, V Pinsk, J Levy.   

Abstract

Thirteen patients with congenital insensitivity to pain and anhidrosis, carrying a mutation at the TRK-A gene, were studied. Neurologic examination revealed vestigial pain sensitivity, suggesting an incomplete involvement of the affected nerves. All 13 patients manifested normal electrophysiologic studies but striking absence of sympathetic skin responses. We suggest the use of the sympathetic skin response test in the clinical evaluation of patients suspected of having congenital insensitivity to pain and anhidrosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744315     DOI: 10.1016/s0887-8994(01)00347-2

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  5 in total

1.  Abnormal capacity for grip force control in patients with congenital insensitivity to pain.

Authors:  Noritaka Kawashima; Masaki O Abe; Tsutomu Iwaya; Nobuhiko Haga
Journal:  Exp Brain Res       Date:  2012-03-15       Impact factor: 1.972

2.  Evaluation of nonnociceptive sensation in patients with congenital insensitivity to pain with anhidrosis.

Authors:  Masahiro Iijima; Nobuhiko Haga
Journal:  Childs Nerv Syst       Date:  2009-12-16       Impact factor: 1.475

3.  A case of hereditary sensory autonomic neuropathy type IV.

Authors:  G P Prashanth; Mahesh Kamate
Journal:  Ann Indian Acad Neurol       Date:  2012-04       Impact factor: 1.383

4.  Update Review and Clinical Presentation in Congenital Insensitivity to Pain and Anhidrosis.

Authors:  L M Pérez-López; M Cabrera-González; D Gutiérrez-de la Iglesia; S Ricart; G Knörr-Giménez
Journal:  Case Rep Pediatr       Date:  2015-10-22

5.  The painless eye: Neurotrophic keratitis in a child suffering from hereditary sensory autonomic neuropathy type IV.

Authors:  Aditya Sethi; Srikanth Ramasubramanian; Meenakshi Swaminathan
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.